Cytogenetic abnormalities in multiple myeloma patients according to age: A real‐world study by the Nordic Myeloma Study Group
Open Access
- 23 July 2025
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 207 (4) , 1638-1642
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Impact of cytogenetic abnormalities in symptomatic multiple myeloma; a Japanese real-world analysis from Kansai Myeloma ForumLeukemia Research Reports, 2023
- Impact of 1q gains on treatment outcomes of patients with newly diagnosed multiple myeloma in a real‐world Swedish population receiving modern treatmentEuropean Journal of Haematology, 2023
- Prognostic value of t(4;14) translocation in newly diagnosed multiple myeloma patients in novel agent eraHematology, 2023
- Development and Validation of a Cytogenetic Prognostic Index Predicting Survival in Multiple MyelomaJournal of Clinical Oncology, 2019
- Rapidly changing myeloma epidemiology in the general population: Increased incidence, older patients, and longer survivalEuropean Journal of Haematology, 2018
- Natural history of t(11;14) multiple myelomaLeukemia, 2017
- Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working GroupJournal of Clinical Oncology, 2015
- Chromosomal Abnormalities Are Major Prognostic Factors in Elderly Patients With Multiple Myeloma: The Intergroupe Francophone du Myélome ExperienceJournal of Clinical Oncology, 2013
- The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myelomaNature Genetics, 2013
- Age has a profound effect on the incidence and significance of chromosome abnormalities in myelomaLeukemia, 2005